Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
Richard C. Pfenniger, Jr.
Mr. Pfenniger has served as a Director of OPKO since January 2008. Mr. Pfenniger previously served as CEO and President for Continucare Corporation, a provider of primary care physician and practice management services, and as Chairman of the Board of Directors of Continucare Corporation. Mr. Pfenniger has also served as CEO and Vice Chairman of Whitman Education Group.
Prior to joining Whitman, he served as Chief Operating Officer of IVAX and as Senior Vice President-Legal Affairs and General Counsel of IVAX. Mr. Pfenniger currently serves as a Director of GP Strategies Corporation, a corporate education and training company, TransEnterix, a medical device company pioneering the use of robotics, IntegraMed America and BioCardia, a clinical-stage regenerative medicine company. He also serves as Vice Chairman of the Board of Trustees and as a member of the Executive Committee of the Phillip and Patricia Frost Museum of Science.
Prem A. Lachman, M.D.
Dr. Lachman has been a Director of OPKO. He is a healthcare investment manager with more than 35 years of experience in portfolio management, biopharmaceutical investment research and healthcare investment banking. Dr. Lachman founded Maximus Capital in 2001 and currently serves as its general partner. Dr. Lachman previously served as general partner of The Galleon Group and as Managing Director, Investment Research at Goldman Sachs & Co. Dr. Lachman is a Directors Council board member of the Museum of Modern Art, a patron of the Metropolitan Opera and a board member of the Department of Surgery at Mount Sinai Medical Center in New York.
John A. Paganelli
Mr. Paganelli has served as a Director of OPKO since December 2003. Previously, he served as OPKO's interim CEO and Secretary, and Chairman of OPKO's Board of Directors until 2007. Mr. Paganelli also served as President and CEO of Transamerica Life Insurance Company of New York.
Since 1987, Mr. Paganelli has been a partner in RFG Associates, a financial planning organization. Mr. Paganelli is also the Managing Partner of Pharos Systems Partners, an investment company, and served as Chairman of the Board of Pharos Systems International, a software company. He was Vice President and Executive Vice President of PEG Capital Management, an investment advisory organization. Mr. Paganelli was also an officer and director-stockholder of Mike Barnard Chevrolet, an automobile dealership. Mr. Paganelli serves as a Director of Western New York Energy, and previously served on the Board of Trustees of Paul Smith's College and the Board of Managers of Bridge Financial Services.
Prem A. Lachman, M.D.
Dr. Lachman has been a Director of OPKO. He is a healthcare investment manager with more than 35 years of experience in portfolio management, biopharmaceutical investment research and healthcare investment banking. Dr. Lachman founded Maximus Capital in 2001 and currently serves as its general partner. Dr. Lachman previously served as general partner of The Galleon Group and as Managing Director, Investment Research at Goldman Sachs & Co. Dr. Lachman is a Directors Council board member of the Museum of Modern Art, a patron of the Metropolitan Opera and a board member of the Department of Surgery at Mount Sinai Medical Center in New York.
Roger J. Medel, M.D.
Dr. Medel has been a Director of OPKO. He is the co-founder of MEDNAX, a national health solutions partner comprised of the nation’s leading providers of physician services, where he has served as a Director, President and Chief Executive Officer. Dr. Medel serves as a member of the Board of Trustees of the Dana Farber Cancer Institute and was a member of the Board of Trustees of the University of Miami. Dr. Medel actively participates as a member of several medical and professional organizations and previously served on the Board of Directors of MBF Healthcare Acquisition Corp.
John A. Paganelli
Mr. Paganelli has served as a Director of OPKO since December 2003. Previously, he served as OPKO's interim CEO and Secretary, and Chairman of OPKO's Board of Directors until 2007. Mr. Paganelli also served as President and CEO of Transamerica Life Insurance Company of New York.
Since 1987, Mr. Paganelli has been a partner in RFG Associates, a financial planning organization. Mr. Paganelli is also the Managing Partner of Pharos Systems Partners, an investment company, and served as Chairman of the Board of Pharos Systems International, a software company. He was Vice President and Executive Vice President of PEG Capital Management, an investment advisory organization. Mr. Paganelli was also an officer and director-stockholder of Mike Barnard Chevrolet, an automobile dealership. Mr. Paganelli serves as a Director of Western New York Energy, and previously served on the Board of Trustees of Paul Smith's College and the Board of Managers of Bridge Financial Services.
Prem A. Lachman, M.D.
Dr. Lachman has been a Director of OPKO. He is a healthcare investment manager with more than 35 years of experience in portfolio management, biopharmaceutical investment research and healthcare investment banking. Dr. Lachman founded Maximus Capital in 2001 and currently serves as its general partner. Dr. Lachman previously served as general partner of The Galleon Group and as Managing Director, Investment Research at Goldman Sachs & Co. Dr. Lachman is a Directors Council board member of the Museum of Modern Art, a patron of the Metropolitan Opera and a board member of the Department of Surgery at Mount Sinai Medical Center in New York.
Roger J. Medel, M.D.
Dr. Medel has been a Director of OPKO. He is the co-founder of MEDNAX, a national health solutions partner comprised of the nation’s leading providers of physician services, where he has served as a Director, President and Chief Executive Officer. Dr. Medel serves as a member of the Board of Trustees of the Dana Farber Cancer Institute and was a member of the Board of Trustees of the University of Miami. Dr. Medel actively participates as a member of several medical and professional organizations and previously served on the Board of Directors of MBF Healthcare Acquisition Corp.
Prem A. Lachman, M.D.
Dr. Lachman has been a Director of OPKO. He is a healthcare investment manager with more than 35 years of experience in portfolio management, biopharmaceutical investment research and healthcare investment banking. Dr. Lachman founded Maximus Capital in 2001 and currently serves as its general partner. Dr. Lachman previously served as general partner of The Galleon Group and as Managing Director, Investment Research at Goldman Sachs & Co. Dr. Lachman is a Directors Council board member of the Museum of Modern Art, a patron of the Metropolitan Opera and a board member of the Department of Surgery at Mount Sinai Medical Center in New York.
John A. Paganelli
Mr. Paganelli has served as a Director of OPKO since December 2003. Previously, he served as OPKO's interim CEO and Secretary, and Chairman of OPKO's Board of Directors until 2007. Mr. Paganelli also served as President and CEO of Transamerica Life Insurance Company of New York.
Since 1987, Mr. Paganelli has been a partner in RFG Associates, a financial planning organization. Mr. Paganelli is also the Managing Partner of Pharos Systems Partners, an investment company, and served as Chairman of the Board of Pharos Systems International, a software company. He was Vice President and Executive Vice President of PEG Capital Management, an investment advisory organization. Mr. Paganelli was also an officer and director-stockholder of Mike Barnard Chevrolet, an automobile dealership. Mr. Paganelli serves as a Director of Western New York Energy, and previously served on the Board of Trustees of Paul Smith's College and the Board of Managers of Bridge Financial Services.
Richard C. Pfenniger, Jr.
Mr. Pfenniger has served as a Director of OPKO since January 2008. Mr. Pfenniger previously served as CEO and President for Continucare Corporation, a provider of primary care physician and practice management services, and as Chairman of the Board of Directors of Continucare Corporation. Mr. Pfenniger has also served as CEO and Vice Chairman of Whitman Education Group.
Prior to joining Whitman, he served as Chief Operating Officer of IVAX and as Senior Vice President-Legal Affairs and General Counsel of IVAX. Mr. Pfenniger currently serves as a Director of GP Strategies Corporation, a corporate education and training company, TransEnterix, a medical device company pioneering the use of robotics, IntegraMed America and BioCardia, a clinical-stage regenerative medicine company. He also serves as Vice Chairman of the Board of Trustees and as a member of the Executive Committee of the Phillip and Patricia Frost Museum of Science.
John A. Paganelli
Mr. Paganelli has served as a Director of OPKO since December 2003. Previously, he served as OPKO's interim CEO and Secretary, and Chairman of OPKO's Board of Directors until 2007. Mr. Paganelli also served as President and CEO of Transamerica Life Insurance Company of New York.
Since 1987, Mr. Paganelli has been a partner in RFG Associates, a financial planning organization. Mr. Paganelli is also the Managing Partner of Pharos Systems Partners, an investment company, and served as Chairman of the Board of Pharos Systems International, a software company. He was Vice President and Executive Vice President of PEG Capital Management, an investment advisory organization. Mr. Paganelli was also an officer and director-stockholder of Mike Barnard Chevrolet, an automobile dealership. Mr. Paganelli serves as a Director of Western New York Energy, and previously served on the Board of Trustees of Paul Smith's College and the Board of Managers of Bridge Financial Services.